Gsa Capital Partners LLP Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Gsa Capital Partners LLP

  • $1.19 Billion
  • Q1 2024

A detailed history of Gsa Capital Partners LLP transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Gsa Capital Partners LLP holds 18,609 shares of PPH stock, worth $1.7 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
18,609
Previous 9,865 88.64%
Holding current value
$1.7 Million
Previous $802,000 110.35%
% of portfolio
0.14%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$82.63 - $90.89 $722,516 - $794,742
8,744 Added 88.64%
18,609 $1.69 Million
Q4 2023

Feb 16, 2024
SELL
$74.32 - $81.37 $248,600 - $272,182
-3,345 Reduced 25.32%
9,865 $802,000
Q3 2023

Nov 15, 2023
BUY
$76.26 - $83.18 $112,864 - $123,106
1,480 Added 12.62%
13,210 $1.05 Million
Q2 2023

Aug 14, 2023
BUY
$75.02 - $80.55 $216,507 - $232,467
2,886 Added 32.63%
11,730 $923,000
Q1 2023

May 12, 2023
BUY
$73.68 - $79.63 $651,625 - $704,247
8,844 New
8,844 $686,000

Others Institutions Holding PPH

# of Institutions
139
Shares Held
4.66M
Call Options Held
18K
Put Options Held
5.5K
View Full List

About VANECK ETF TR VANECK PHARMACEU

PPH Quotes by TradingView
  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email